🤖 Search 5,000+ AI tools Ask our bot for help →

Discover the latest tools and trends in AI 🔮

Join 60,000+ subscribers including Amazon, Apple, Google, and Microsoft employees reading our free newsletter.

[email protected] Subscribe

Triomics secures $15M in new funding round

Triomics secures $15M in new funding round
Triomics secures $15M in new funding round

Triomics, a San Francisco-based startup in AI for cancer care, raised $15M in funding.

Investors include Lightspeed, Nexus Venture Partners, General Catalyst, and Y Combinator.

Funds will be used for expanding operations and development efforts, specifically enhancing OncoLLM™ and related software.

Triomics, led by CEO Sarim Khan and CTO Hrituraj Singh, specializes in AI systems like OncoLLM™ to improve cancer treatment workflows, patient-trial matching, and precision oncology.

Comments